Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

15 citing papers in PubMed.

1. From crops to clinic: the impact of dual azole use on antifungal resistance inFrontiers in microbiology · 2025
   Review
2. Detection in Orchards of Predominant Azole-Resistant Candida tropicalis Genotype Causing Human Candidemia, Taiwan.Emerging infectious diseases · 2024
   Article
3. Collateral consequences of agricultural fungicides on pathogenic yeasts: A One Health perspective to tackle azole resistance.Mycoses · 2022
   Review
4. Fungicide effects on human fungal pathogens: Cross-resistance to medical drugs and beyond.PLoS pathogens · 2021
   Review
5. Azole-Resilient Biofilms and Non-wild Type C. albicans Among Candida Species Isolated from Agricultural Soils Cultivated with Azole Fungicides: an Environmental Issue?Microbial ecology · 2021
   Article
6. Assessing the Risk for Resistance and Elucidating the Genetics ofFrontiers in microbiology · 2017
   Article
7. Antifungal Resistance and Virulence Among Candida spp. from Captive Amazonian manatees and West Indian Manatees: Potential Impacts on Animal and Environmental Health.EcoHealth · 2016
   Article
8. Clonal expansion and emergence of environmental multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR₃₄/L98H mutations in the cyp51A gene in India.PloS one · 2012
   Article
9. Comparison of human and soil Candida tropicalis isolates with reduced susceptibility to fluconazole.PloS one · 2012
   Article
10. In vitro susceptibility of the yeast pathogen cryptococcus to fluconazole and other azoles varies with molecular genotype.Journal of clinical microbiology · 2010
    Article
11. Azole drugs are imported by facilitated diffusion in Candida albicans and other pathogenic fungi.PLoS pathogens · 2010
    Article
12. Treatment of a clinically relevant plant-pathogenic fungus with an agricultural azole causes cross-resistance to medical azoles and potentiates caspofungin efficacy.Antimicrobial agents and chemotherapy · 2007
    Article
13. Azole resistance in Candida spp. isolated from Catú Lake, Ceará, Brazil: an efflux-pump-mediated mechanism.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]
    Article
14. The impact of climate change on the epidemiology of fungal infections: implications for diagnosis, treatment, and public health strategies.Therapeutic advances in infectious disease
    Review
15. Is the emergence of fungal resistance to medical triazoles related to their use in the agroecosystems? A mini review.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

6 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as